Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1962 1
1963 2
1970 2
1972 2
1983 1
1984 1
1985 3
1986 2
1988 1
1989 5
1990 7
1991 4
1992 7
1993 8
1994 3
1995 4
1996 3
1997 4
1998 6
1999 8
2000 7
2001 15
2002 11
2003 8
2004 14
2005 10
2006 17
2007 13
2008 11
2009 5
2010 7
2011 4
2012 5
2013 6
2014 12
2015 4
2016 6
2017 5
2018 7
2019 17
2020 11
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

254 results
Results by year
Filters applied: . Clear all
Page 1
Rapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation Burden.
Makimoto G, Ohashi K, Tomida S, Nishii K, Matsubara T, Kayatani H, Higo H, Ninomiya K, Sato A, Watanabe H, Kano H, Ninomiya T, Kubo T, Rai K, Ichihara E, Hotta K, Tabata M, Toyooka S, Takata M, Maeda Y, Kiura K. Makimoto G, et al. Among authors: nishii k. J Thorac Oncol. 2019 Nov;14(11):2009-2018. doi: 10.1016/j.jtho.2019.07.017. Epub 2019 Jul 30. J Thorac Oncol. 2019. PMID: 31374369 Free article.
VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers.
Watanabe H, Ichihara E, Kayatani H, Makimoto G, Ninomiya K, Nishii K, Higo H, Ando C, Okawa S, Nakasuka T, Kano H, Hara N, Hirabae A, Kato Y, Ninomiya T, Kubo T, Rai K, Ohashi K, Hotta K, Tabata M, Maeda Y, Kiura K. Watanabe H, et al. Among authors: nishii k. Cancer Sci. 2021 May;112(5):1853-1864. doi: 10.1111/cas.14801. Epub 2021 Mar 18. Cancer Sci. 2021. PMID: 33410241 Free PMC article.
254 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page